Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001140361-09-014977

Options or other derivatives

  • Chief Executive Officer acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

DEES H CRAIG · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2009-06-19 Grant or award : show line 1 in the form Stock Options (right to buy) +50,000 $1.04 2019-06-19 50,000 50,000 D
Loading xslF345X03/doc1.xml…